US2015273014A1PendingUtilityA1
Use of peptides for promoting wound healing
Assignee: RAPID PATHOGEN SCREENING INCPriority: Jan 7, 2008Filed: Jun 10, 2015Published: Oct 1, 2015
Est. expiryJan 7, 2028(~1.5 yrs left)· nominal 20-yr term from priority
Inventors:Johannes Gerhardus Maria BolscherArie Van Nieuw AmerongenEngelmundus Cornelis Ignatius VeermanMenno Johannes OudhoffWillem Van'T HofKamran NazmiPetronella Adriana Maria Van Den Keijbus
A61K 38/12A61K 38/16C07K 7/64A61K 38/10A61K 38/08C07K 7/06C07K 14/4723A61K 45/06A61K 38/1709A61K 38/1729A61K 38/18
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The current invention relates to the use of a peptide comprising an amino acid sequence in the preparation of a medicament for the regeneration of tissue, preferably for the treatment of a wound. Further the invention relates to compositions comprising such peptides, and use of said peptides in both medical and nonmedical (cosmetic) applications.
Claims
exact text as granted — not AI-modified1 - 35 . (canceled)
36 . A composition comprising a peptide and at least one pharmaceutically acceptable excipient, wherein the peptide comprises at least six contiguous residues of the amino acid sequence of SEQ ID NO: 5 or a variant peptide thereof in which one amino acid residue is substituted, deleted or inserted within said at least six contiguous residues, wherein the peptide is a cyclic peptide.
37 . The composition of claim 36 , wherein the sequence of said at least six contiguous residues is selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2 and SEQ ID NO: 3.
38 . The composition of claim 36 , wherein the sequence of said at least six contiguous residues comprises at least six contiguous residues of SEQ ID NO: 2.
39 . The composition of claim 36 , wherein the cyclic peptide comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 1-29 or a variant thereof in which one amino acid residue in any of SEQ ID NOs: 4-29 is substituted, deleted or inserted and the one residue substitution, deletion or insertion is not within a subsequence of SEQ ID NOs: 1-3.
40 . The composition of claim 36 , wherein the cyclic peptide has a relative wound closure activity that is equal to the relative wound closure activity of 1 μM concentration of the linear peptide of SEQ ID NO: 4 but at a concentration of cyclic peptide that is at least 5 times lower.
41 . The composition of claim 36 , wherein the peptide has the sequence of SEQ ID NO: 2.
42 . The composition of claim 36 , wherein the cyclic peptide comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 5, 7-20, 23-25, and 28-29 or a variant thereof in which one amino acid residue in any of SEQ ID NOs: 4, 5, 7-20, 23-25, and 28-29 is substituted, deleted or inserted and the one residue substitution, deletion or insertion is not within a subsequence of SEQ ID NO: 2.Join the waitlist — get patent alerts
Track US2015273014A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.